Skip to main content

Currently Skimming:

Appendix B: Agenda: Issues of Resistance: Microbes,Vectors, and the Host
Pages 244-248

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 244...
... 1 0:45 10:30 am Welcome and Opening Remarks Adel Mahmoud, Chair, Forum on Emerging Infections President, Merck Vaccines Arms Races with Evolving Diseases: Patterns, Costs and Containment Stephen Palumbi, Harvard University Session I: Case Studies of Antimicrobial Resistance Moderator: Carios Lopez, Eli Lilly 1 1:15 The Cost of Antimicrobial Resistance Richard Smith, University of East Anglia, United Kingdom Resistant Strains of Pneumococci, Staphylococci, and Enterococci Alexander Tomasz, Laboratory of Microbiology, Rockefeller University 12:15 pm LUNCH 1 1:45 244
From page 245...
... APPENDIX B 245 1:30 Resistance to HIV-1 Drug Therapies Robert Redfield, The Institute of Human Virology, University of Maryland 2:00 Chioroquine-Resistant Malaria Thomas Wellems, National Institute for Allergy and Infectious Diseases, NIH 2:30 Schistosomiasis and Antibelminth Resistance Charles King, Division of Geographic Medicine, Case Western Reserve University 3:00 Epitope Escape Variants Robert Webster, St. Jude Children's Research Hospital and World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds Session II: Vector Resistance 4:00 4:30 Moderator: Barry Beaty, Colorado State University 3:30 Pesticide Resistance: Implications for Disease Emergence and Control Janet Hemingway, Liverpool School of Tropical Medicine, United Kingdom Studies in Antibiotic Resistance and Insecticide Resistance: Commonalties, Differences, and New Directions Steven Peck, Zoology Department, Brigham Young University Managing the Emergence of Pesticide Resistance in Disease Vectors William Brogdon, Division of Parasitic Diseases, Centers for Disease Control and Prevention Session III: Discussion Panel Moderator: Carole Heilman, National Institute for Allergy and Infectious Diseases 5:00 6:00 6:15 William Jack, Georgetown University Lynn Marks, GlaxoSmith Kline Steve Brickner, Pfizer Adjournment of the first day DINNER MEETING OF THE FORUM ON EMERGING INFECTIONS
From page 246...
... 246 THURSDAY, FEBRUARY 7, 2002 9:00 THE RESISTANCE PHENOMENON Continental Breakfast Opening Remarks / Summary of Day 1 Stanley Lemon, Vice Chair, Forum on Emerging Infections Dean of Medicine, The University of Texas Medical Branch, Galveston 9:15 Antibiotic Resistance 1992-2002: A Decade's tourney Stuart Levy, School of Medicine, Tufts University Session IV: Factors of Emergence Moderator: Mary Wilson, Harvard University 9:45 Patterns of Use for Antimicrobials in Developing Countries Iruka Okeke, University of Bradford, United Kingdom Health Care-Acquired Infections: Hospitals and Long-Term Care Facilities as Breeding Grounds for Antimicrobial Resistance Lindsay Nicolle, University of Manitoba, Canada The Use of Antimicrobials in Food-Producing Animals Thomas Shryock, Elanco Lilly Research Special Considerations: Anthrax, Large-Scale/Long-Term Prophylaxis or Therapy and the Emergence of Microbial Resistance Thomas Elliott, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health 10:15 1 0:45 11:15 Sciences Session V: Containing the Development of Resistance Moderator: lames Hughes, Centers for Disease Control and Prevention 11:45 Emergence of Multiple Mechanisms of Resistance to Antibacterials Shahriar Mobashery, Department of Biochemistry, Wayne State University 12:15 pm Emerging Technologies to Combat Resistance: Opportunities and Limitations Vincent Fischetti, Laboratory of Bacterial Pathogenesis, Rockefeller University LUNCH 12:45
From page 247...
... The discussion of priorities will summarize the issues surrounding emerging opportunities for more effective collaboration as well as the remaining research and programmatic needs. The confounding issues of the major obstacles to preparing an optimal response, particularly as it relates to the complexities of interaction between private industry, research and public health agencies, regulatory agencies, policymakers, academic researchers, and the public will be explored with an eye toward innovative responses to such challenges.
From page 248...
... 248 i:30 ~ ICE P~0~0N Panel Discussants: Ram anon [~%minarayan, Resources for the Future Icy Torrance, O.S. Department of Agriculture, Cooperative State Research Education and Extension Service Donald Roberts, Uniformed Services University of the Health Sciences Adjourn

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.